BiondVax Pharmaceuticals Ltd. - American Depositary Shares (NQ:BVXV)

N/A UNCHANGED

Last Price Updated: 3:59 PM EDT, Sep 6, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BiondVax Pharmaceuticals Ltd. - American Depositary Shares

< Previous 1 2 3 Next >

Stocks That Hit 52-Week Lows On Tuesday ↗

June 13, 2023

On Tuesday, 32 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 06, 2023

On Tuesday, 69 stocks hit new 52-week lows.

Via Benzinga

BiondVax Touts Additional Preclinical Data From Inhaled COVID-19 Treatment Candidate ↗

January 23, 2023

Via Benzinga

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 05, 2023

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket ↗

January 19, 2023

Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 10, 2023

Tuesday's session saw 16 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 06, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 03, 2023

On Tuesday, 31 stocks hit new 52-week lows.

Via Benzinga

Why Biondvax Pharmaceuticals Stock Is Getting Obliterated During Friday's Trading Session ↗

December 16, 2022

Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading lower by 58.60% to $3.64 during Friday's session after the company priced its 1.6 million unit offering at $5 per unit.

Via Benzinga

Dow Tumbles 400 Points; Maxar Technologies Shares Spike Higher ↗

December 16, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 400 points on Friday.

Via Benzinga

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗

December 16, 2022

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.

Via Benzinga

Nasdaq Falls Over 100 Points; Crude Oil Drops Sharply ↗

December 16, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 16, 2022

Via Benzinga

Dow Drops 200 Points; Accenture Posts Upbeat Results ↗

December 16, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday.

Via Benzinga

Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session ↗

November 25, 2022

Gainers Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08.

Via Benzinga

Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗

November 28, 2022

Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 11, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 29, 2022

Gainers

Via Benzinga

Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday ↗

September 30, 2022

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 29, 2022

Gainers

Via Benzinga

BiondVax Pharmaceuticals: Q2 Earnings Insights ↗

August 25, 2022

BiondVax Pharmaceuticals (NASDAQ:BVXV) reported its Q2 earnings results on Thursday, August 25, 2022 at 07:10 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 25, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 20, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 13, 2022

Gainers Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $38.0 million. As per the news, the Q1...

Via Benzinga

80 Biggest Movers From Yesterday ↗

May 04, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 25, 2022

Gainers Tilray Brands (NASDAQ:TLRY) stock increased by 17.2% to $8.17 during Friday's pre-market session. The company's market cap stands at $3.9 billion. Sundial...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.